171 related articles for article (PubMed ID: 16989181)
1. [Therapy of hepatitis B].
Thimme R; Blum HE
Praxis (Bern 1994); 2006 Sep; 95(36):1383-8. PubMed ID: 16989181
[TBL] [Abstract][Full Text] [Related]
2. [Hepatitis B (acute and chronic)].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Jul; 93(31-32):1227-33; quiz 1234, 1261. PubMed ID: 15453144
[No Abstract] [Full Text] [Related]
3. [Therapy of hepatitis B virus infection].
Trautwein C
Praxis (Bern 1994); 2006 Sep; 95(36):1389-97. PubMed ID: 16989182
[TBL] [Abstract][Full Text] [Related]
4. [Management of chronic hepatitis B].
von Weizsäcker F
Praxis (Bern 1994); 2005 Apr; 94(16):649-52. PubMed ID: 15900829
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological agents for the treatment of chronic hepatitis B].
Sánchez-Tapias JM
Gastroenterol Hepatol; 2008 Mar; 31(3):120-8. PubMed ID: 18341843
[No Abstract] [Full Text] [Related]
6. Antiviral therapy in patients with chronic hepatitis B and cirrhosis.
Lai CJ; Terrault NA
Gastroenterol Clin North Am; 2004 Sep; 33(3):629-54, x-xi. PubMed ID: 15324948
[TBL] [Abstract][Full Text] [Related]
7. Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.
Nguyen MH; Keeffe EB
J Viral Hepat; 2009 Mar; 16(3):149-55. PubMed ID: 19236641
[TBL] [Abstract][Full Text] [Related]
8. Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants.
Liu CJ; Kao JH; Chen PJ; Chen TC; Lin FY; Lai MY; Chen DS
J Viral Hepat; 2006 Jun; 13(6):387-95. PubMed ID: 16842441
[TBL] [Abstract][Full Text] [Related]
9. Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.
Limquiaco JL; Wong J; Wong VW; Wong GL; Tse CH; Chan HY; Kwan KY; Lai PB; Chan HL
J Med Virol; 2009 Feb; 81(2):224-9. PubMed ID: 19107976
[TBL] [Abstract][Full Text] [Related]
10. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
Wiegand J; Tischendorf JJ; Nashan B; Klempnauer J; Flemming P; Niemann P; Rohde P; Manns MP; Trautwein C; Tillmann HL
Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399
[TBL] [Abstract][Full Text] [Related]
11. [New antiviral agent. Hepatitis B therapy with slight resistance risk].
MMW Fortschr Med; 2003 Dec; 145(51-52):40. PubMed ID: 14974332
[No Abstract] [Full Text] [Related]
12. Antiviral therapy for treatment-naïve hepatitis B virus patients.
Lau DT; Membreno FE
Gastroenterol Clin North Am; 2004 Sep; 33(3):581-99, ix-x. PubMed ID: 15324945
[TBL] [Abstract][Full Text] [Related]
13. Adefovir dipivoxil: new preparation. A third-line option in chronic hepatitis B.
Prescrire Int; 2004 Feb; 13(69):4-7. PubMed ID: 15055205
[TBL] [Abstract][Full Text] [Related]
14. Current treatment of chronic hepatitis B.
Montazeri G
Arch Iran Med; 2006 Jan; 9(1):1-10. PubMed ID: 16649370
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients.
Aizawa M; Tsubota A; Fujise K; Tatsuzawa K; Kono M; Hoshina S; Tajiri H
J Med Virol; 2011 Jun; 83(6):953-61. PubMed ID: 21503906
[TBL] [Abstract][Full Text] [Related]
16. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.
Papatheodoridis GV; Dimou E; Dimakopoulos K; Manolakopoulos S; Rapti I; Kitis G; Tzourmakliotis D; Manesis E; Hadziyannis SJ
Hepatology; 2005 Jul; 42(1):121-9. PubMed ID: 15962291
[TBL] [Abstract][Full Text] [Related]
17. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
Manolakopoulos S; Bethanis S; Koutsounas S; Goulis J; Vlachogiannakos J; Christias E; Saveriadis A; Pavlidis C; Triantos C; Christidou A; Papatheodoridis G; Karamanolis D; Tzourmakliotis D
Aliment Pharmacol Ther; 2008 Feb; 27(3):266-73. PubMed ID: 17988233
[TBL] [Abstract][Full Text] [Related]
18. [Management of hepatitis B].
de Gottardi A; Negro F
Ther Umsch; 2004 Aug; 61(8):487-91. PubMed ID: 15457964
[TBL] [Abstract][Full Text] [Related]
19. [Clinical management of patients with chronic hepatitis B virus infection].
Rodríguez M; González-Diéguez ML
Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():56-65. PubMed ID: 19100232
[TBL] [Abstract][Full Text] [Related]
20. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
Ong A; Wong VW; Wong GL; Chan HY; Tse CH; Chan HL
Aliment Pharmacol Ther; 2011 Oct; 34(8):972-81. PubMed ID: 21883327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
